Drug maker Alkem Laboratories Ltd reported 13.5 percent drop in net profit at Rs 454.7 crore for the December quarter as against Rs 525 crore a year ago. However, the company's latest quarter net profit was 9.2 percent higher than Street estimates of Rs 416.4 crore.

Share Market Live

NSE

Its revenue of Rs 3,040 crore was 16.1 percent higher than the year ago quarter and 2.2 percent more than Street estimates. In the third quarter of last fiscal, the pharma company reported a revenue of Rs 2,619 crore and the CNBC-TV18 poll had estimated the same to come in at Rs 2,976 crore for this year's Q3.

Alkem Labs reported its earnings before interest, taxes, depreciation, and amortisation (EBITDA) at Rs 599.1 percent, which was 34.7 percent higher than the CNBC-TV18 poll estimate of Rs 444.7 crore. Its margin was 19.7 percent for the December quarter, close to last year's 19 percent.

In the third quarter last fiscal, it reported an EBITDA of Rs 498.4 crore.

Also Read: LIC jumps 4% on stellar December quarter results

First Published:Feb 10, 2023 4:32 PM IST